Structure Database (LMSD)

LM_ID Common Name Systematic Name Main class Sub class Mass Formula
LMSP0601AA05 GM4(d18:1/24:0) NeuAcalpha2-3Galbeta-Cer(d18:1/24:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1102.79 C59H110N2O16
LMSP0601AA07 GM4(d18:1/24:1(15Z)) NeuAcalpha2-3Galbeta-Cer(d18:1/24:1(15Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1100.77 C59H108N2O16
LMSP0601AA06 GM4(d18:1/26:0) NeuAcalpha2-3Galbeta-Cer(d18:1/26:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1130.82 C61H114N2O16
LMSP0601AA08 GM4(d18:1/26:1(17Z)) NeuAcalpha2-3Galbeta-Cer(d18:1/26:1(17Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1128.8 C61H112N2O16
LMSP0601AX01 GP1c(d18:1/16:0) NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2682.23 C115H195N7O63
LMSP0601AX02 GP1c(d18:1/18:0) NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2710.26 C117H199N7O63
LMSP0601AX03 GP1c(d18:1/20:0) NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2738.29 C119H203N7O63
LMSP0601AX04 GP1c(d18:1/22:0) NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2766.32 C121H207N7O63
LMSP0601AX05 GP1c(d18:1/24:0) NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2794.35 C123H211N7O63
LMSP0601AX07 GP1c(d18:1/24:1(15Z)) NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2792.34 C123H209N7O63
LMSP0601AX06 GP1c(d18:1/26:0) NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2822.38 C125H215N7O63
LMSP0601AX08 GP1c(d18:1/26:1(17Z)) NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2820.37 C125H213N7O63
LMSP0601BO01 GQ1aa(d18:1/16:0) NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2391.13 C104H178N6O55
LMSP0601BO02 GQ1aa(d18:1/18:0) NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2419.16 C106H182N6O55
LMSP0601BO03 GQ1aa(d18:1/20:0) NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2447.19 C108H186N6O55
LMSP0601BO04 GQ1aa(d18:1/22:0) NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2475.23 C110H190N6O55
LMSP0601BO05 GQ1aa(d18:1/24:0) NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2503.26 C112H194N6O55
LMSP0601BO07 GQ1aa(d18:1/24:1(15Z)) NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2501.24 C112H192N6O55
LMSP0601BO06 GQ1aa(d18:1/26:0) NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2531.29 C114H198N6O55
LMSP0601BO08 GQ1aa(d18:1/26:1(17Z)) NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2529.27 C114H196N6O55
LMSP0601AV01 GQ1b(d18:1/16:0) NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2391.13 C104H178N6O55
LMSP0601CU01 GQ1b(d18:1/16:0) NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2391.13 C104H178N6O55
LMSP0601CU02 GQ1b(d18:1/18:0) NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2419.16 C106H182N6O55
LMSP0601AV02 GQ1b(d18:1/18:0) NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2419.16 C106H182N6O55
LMSP0601CU03 GQ1b(d18:1/20:0) NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2447.19 C108H186N6O55
LMSP0601AV03 GQ1b(d18:1/20:0) NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2447.19 C108H186N6O55
LMSP0601CU04 GQ1b(d18:1/22:0) NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2475.23 C110H190N6O55
LMSP0601AV04 GQ1b(d18:1/22:0) NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2475.23 C110H190N6O55
LMSP0601AV05 GQ1b(d18:1/24:0) NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2503.26 C112H194N6O55
LMSP0601CU05 GQ1b(d18:1/24:0) NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2503.26 C112H194N6O55
LMSP0601AV07 GQ1b(d18:1/24:1(15Z)) NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2501.24 C112H192N6O55
LMSP0601CU07 GQ1b(d18:1/24:1(15Z)) NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2501.24 C112H192N6O55
LMSP0601CU06 GQ1b(d18:1/26:0) NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2531.29 C114H198N6O55
LMSP0601AV06 GQ1b(d18:1/26:0) NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2531.29 C114H198N6O55
LMSP0601AV08 GQ1b(d18:1/26:1(17Z)) NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2529.27 C114H196N6O55
LMSP0601CU08 GQ1b(d18:1/26:1(17Z)) NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2529.27 C114H196N6O55
LMSP0601BJ01 GQ1ba(d18:1/16:0) NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2391.13 C104H178N6O55
LMSP0601BJ02 GQ1ba(d18:1/18:0) NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2419.16 C106H182N6O55
LMSP0601BJ03 GQ1ba(d18:1/20:0) NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2447.19 C108H186N6O55
LMSP0601BJ04 GQ1ba(d18:1/22:0) NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2475.23 C110H190N6O55
LMSP0601BJ05 GQ1ba(d18:1/24:0) NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2503.26 C112H194N6O55
LMSP0601BJ07 GQ1ba(d18:1/24:1(15Z)) NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2501.24 C112H192N6O55
LMSP0601BJ06 GQ1ba(d18:1/26:0) NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2531.29 C114H198N6O55
LMSP0601BJ08 GQ1ba(d18:1/26:1(17Z)) NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2529.27 C114H196N6O55
LMSP0601AU01 GQ1c(d18:1/16:0) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2391.13 C104H178N6O55
LMSP0601AU02 GQ1c(d18:1/18:0) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2419.16 C106H182N6O55
LMSP0601AU03 GQ1c(d18:1/20:0) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2447.19 C108H186N6O55
LMSP0601AU04 GQ1c(d18:1/22:0) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2475.23 C110H190N6O55
LMSP0601AU05 GQ1c(d18:1/24:0) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2503.26 C112H194N6O55
LMSP0601AU07 GQ1c(d18:1/24:1(15Z)) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2501.24 C112H192N6O55